Advanced search
Publication Cover
Biomarkers in Medicine Volume 3, 2009 - Issue 5
Submit an article Journal homepage
273
Views
1
CrossRef citations to date
0
Altmetric
Theme: Biomarkers: paving the way for better stratification in heart failure - Review

ST2 Protein in Heart Disease: From Discovery to Mechanisms and Prognostic Value

Ellen O WeinbergBoston Medical Center,EBRC Room 704,650 Albany Street,Boston,MA 02118,USA. Correspondence[email protected]
Pages 495-511 | Published online: 08 Oct 2009

Bibliography

  • O‘Neill LA : The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress.Immunol. Rev.226, 10–18 (2008).
  • Iwahana H , YanagisawaK, Ito-KosakaAet al. : Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells.Eur. J. Biochem.264, 397–406 (1999).
  • Hayakawa M , YanagisawaK, AokiS, HayakawaH, TakezakoN, TominagaS: T-helper type 2 cell-specific expression of the ST2 gene is regulated by transcription factor GATA-3.Biochim. Biophys. Acta1728, 53–64 (2005).
  • Sims JE , MarchCJ, CosmanDet al. : cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.Science241, 585–589 (1988).
  • Sims JE , AcresRB, GrubinCEet al. : Cloning the interleukin-1 receptor from human T cells.Proc. Natl Acad. Sci. USA86, 8946–8950 (1989).
  • Tominaga S : A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin-1 receptor.FEBS Lett.258, 301–304 (1989).
  • Tominaga S , YokotaT, YanagisawaK, TsukamotoT, TakagiT, TetsukaT: Nucleotide sequence of a complementary DNA for human ST2.Biochim. Biophys. Acta1171, 215–218 (1992).
  • Yanagisawa K , TakagiT, TsukamotoT, TetsukaT, TominagaS: Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin-1 receptor type 1.FEBS Lett.318, 83–87 (1993).
  • Li H , TagoK, IoKet al. : The cloning and nucleotide sequence of human ST2L cDNA.Genomics67, 284–290 (2000).
  • Tominaga S , KuroiwaK, TagoK, IwahanaH, YanagisawaK, KomatsuN: Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7 GM.Biochem. Biophys. Res. Commun.264, 14–18 (1999).
  • Xu D , ChanWL, LeungBPet al. : Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells.J. Exp. Med.187, 787–794 (1998).
  • Lohning M , StroehmannA, CoyleAJet al. : T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin-4, interleukin-5, and interleukin-10, and important for Th2 effector function.Proc. Natl Acad. Sci. USA95, 6930–6935 (1998).
  • Kumar S , MinnichMD, YoungPR: ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin-1.J. Biol. Chem.270, 27905–27913 (1995).
  • Gayle MA , SlackJL, BonnertTPet al. : Cloning of a putative ligand for the T1/ST2 receptor.J. Biol. Chem.271, 5784–5789 (1996).
  • Schmitz J , OwyangA, OldhamEet al. : IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.Immunity23, 479–490 (2005).
  • Oshikawa K , YanagisawaK, TominagaS, SugiyamaY: ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation.Biochem. Biophys. Res. Commun.299, 18–24 (2002).
  • Baekkevold ES , RoussigneM, YamanakaTet al. : Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules.Am. J. Pathol.163, 69–79 (2003).
  • Carriere V , RousselL, OrtegaNet al. : IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.Proc. Natl Acad. Sci. USA104, 282–287 (2007).
  • Cayrol C , GirardJP: The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1.Proc. Natl Acad. Sci. USA106, 9021–9026 (2009).
  • Luthi AU , CullenSP, McNeelaEAet al. : Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.Immunity31(1), 84–98 (2009).
  • Kuchler AM , PollheimerJ, BaloghJet al. : Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation.Am. J. Pathol.173, 1229–1242 (2008).
  • Hammad H , ChieppaM, PerrosF, WillartMA, GermainRN, LambrechtBN: House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells.Nat. Med.15, 410–416 (2009).
  • Hudson CA , ChristophiGP, GruberRCet al. : Induction of IL-33 expression and activity in central nervous system glia.J. Leukoc. Biol.84, 631–643 (2008).
  • Sakashita M , YoshimotoT, HirotaTet al. : Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis.Clin. Exp. Allergy38, 1875–1881 (2008).
  • Moussion C , OrtegaN, GirardJP: The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin‘?PLoS ONE3, E3331 (2008).
  • Roussel L , ErardM, CayrolC, GirardJP: Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocket.EMBO Rep.9, 1006–1012 (2008).
  • Bartunek J , DelrueL, Van Durme F et al.: Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load. J. Am. Coll. Cardiol.52, 2166–2174 (2008).
  • Allakhverdi Z , ComeauMR, JessupHK, DelespesseG: Thymic stromal lymphopoietin as a mediator of crosstalk between bronchial smooth muscles and mast cells.J. Allergy Clin. Immunol.123, 958–960 e2 (2009).
  • Allakhverdi Z , ComeauMR, SmithDEet al. : CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation.J. Allergy Clin. Immunol.123, 472–478 (2009).
  • Saenz SA , TaylorBC, ArtisD: Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites.Immunol. Rev.226, 172–190 (2008).
  • Arend WP , PalmerG, GabayC: IL-1, IL-18, and IL-33 families of cytokines.Immunol. Rev.223, 20–38 (2008).
  • Sanada S , HakunoD, HigginsLJ, SchreiterER, McKenzieAN, LeeRT: IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.J. Clin. Invest.117, 1538–1549 (2007).
  • Palmer G , Talabot-AyerD, LamacchiaCet al. : Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.Arthritis Rheum.60, 738–749 (2009).
  • Palmer G , LipskyBP, SmithgallMDet al. : The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.Cytokine42, 358–364 (2008).
  • Hayakawa H , HayakawaM, KumeA, TominagaS: Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation.J. Biol. Chem.282, 26369–26380 (2007).
  • Ali S , HuberM, KolleweC, BischoffSC, FalkW, MartinMU: IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells.Proc. Natl Acad. Sci. USA104, 18660–18665 (2007).
  • Chackerian AA , OldhamER, MurphyEEet al. : IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.J. Immunol.179, 2551–2555 (2007).
  • Fagundes CT , AmaralFA, SouzaAet al. : ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion.J. Leukoc. Biol.81, 492–499 (2007).
  • Thomassen E , RenshawBR, SimsJE: Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily.Cytokine11, 389–399 (1999).
  • Bulek K , SwaidaniS, QinJet al. : The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response.J. Immunol.182, 2601–2609 (2009).
  • Polentarutti N , RolGP, MuzioMet al. : Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR.Eur. Cytokine Netw.14, 211–218 (2003).
  • Funakoshi-Tago M , TagoK, HayakawaMet al. : TRAF6 is a critical signal transducer in IL-33 signaling pathway.Cell. Signal.20, 1679–1686 (2008).
  • Kuroiwa K , LiH, TagoKet al. : Construction of ELISA system to quantify human ST2 protein in sera of patients.Hybridoma19, 151–159 (2000).
  • Oshikawa K , KuroiwaK, TagoKet al. : Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation.Am. J. Respir. Crit. Care Med.164, 277–281 (2001).
  • Oshikawa K , KuroiwaK, TokunagaTet al. : Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluid.Respir. Med.95, 532–533 (2001).
  • Oshikawa K , YanagisawaK, OhnoS, TominagaS, SugiyamaY: Expression of ST2 in helper T lymphocytes of malignant pleural effusions.Am. J. Respir. Crit. Care Med.165, 1005–1009 (2002).
  • Tajima S , OshikawaK, TominagaS, SugiyamaY: The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis.Chest124, 1206–1214 (2003).
  • Kuroiwa K , AraiT, OkazakiH, MinotaS, TominagaS: Identification of human ST2 protein in the sera of patients with autoimmune diseases.Biochem. Biophys. Res. Commun.284, 1104–1108 (2001).
  • Ali M , ZhangG, ThomasWRet al. : Investigations into the role of ST2 in acute asthma in children.Tissue Antigens73, 206–212 (2009).
  • Shimizu M , MatsudaA, YanagisawaKet al. : Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis.Hum. Mol. Genet.14, 2919–2927 (2005).
  • Cherry WB , YoonJ, BartemesKR, IijimaK, KitaH: A novel IL-1 family cytokine, IL-33, potently activates human eosinophils.J. Allergy Clin. Immunol.121, 1484–1490 (2008).
  • Kearley J , BucklandKF, MathieSA, LloydCM: Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway.Am. J. Respir. Crit. Care Med.179, 772–781 (2009).
  • Kurowska-Stolarska M , KewinP, MurphyGet al. : IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.J. Immunol.181, 4780–4790 (2008).
  • Kondo Y , YoshimotoT, YasudaKet al. : Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system.Int. Immunol.20, 791–800 (2008).
  • Nakajima H , TakatsuK: Role of cytokines in allergic airway inflammation.Int. Arch. Allergy Immunol.142, 265–273 (2007).
  • Schroder NW , MaurerM: The role of innate immunity in asthma: leads and lessons from mouse models.Allergy62, 579–590 (2007).
  • Weinberg EO , ShimpoM, De Keulenaer GW et al.: Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation106, 2961–2966 (2002).
  • Shimpo M , MorrowDA, WeinbergEOet al. : Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction.Circulation109, 2186–2190 (2004).
  • Sabatine MS , MorrowDA, HigginsLJet al. : Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction.Circulation117, 1936–1944 (2008).
  • Weinberg EO , ShimpoM, HurwitzS, TominagaS, RouleauJL, LeeRT: Identification of serum soluble ST2 receptor as a novel heart failure biomarker.Circulation107, 721–726 (2003).
  • Brown AM , WuAH, CloptonP, RobeyJL, HollanderJE: ST2 in emergency department chest pain patients with potential acute coronary syndromes.Ann. Emerg. Med.50, 153–158, E1 (2007).
  • Martinez-Rumayor A , CamargoCA, GreenSM, BaggishAL, O‘DonoghueM, JanuzziJL: Soluble ST2 plasma concentrations predict 1-year mortality in acutely dyspneic emergency department patients with pulmonary disease.Am. J. Clin. Pathol.130, 578–584 (2008).
  • Januzzi JL Jr, Peacock WF, Maisel AS et al.: Measurement of the interleukin-family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J. Am. Coll. Cardiol.50, 607–613 (2007).
  • Dieplinger B , GegenhuberA, HaltmayerM, MuellerT: Evaluation of novel biomarkers for the diagnosis of acute destabilized heart failure in shortness-of-breath patients.Heart doi: 10.1136/hrt.2009.170696 (2009) (Epub ahead of print).
  • Rehman SU , Martinez-RumayorA, MuellerT, JanuzziJL Jr: Independent and incremental prognostic value of multimarker testing in acute dyspnea: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Clin. Chim. Acta392, 41–45 (2008).
  • Rehman SU , MuellerT, JanuzziJL Jr: Characteristics of the novel interleukin-family biomarker ST2 in patients with acute heart failure. J. Am. Coll. Cardiol.52, 1458–1465 (2008).
  • Mueller T , DieplingerB, GegenhuberA, PoelzW, PacherR, HaltmayerM: Increased plasma concentrations of soluble ST2 are predictive for 1--year mortality in patients with acute destabilized heart failure.Clin. Chem.54, 752–756 (2008).
  • Boisot S , BeedeJ, IsaksonSet al. : Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure.J. Card. Fail.14, 732–738 (2008).
  • Szerafin T , NiederpoldT, MangoldAet al. : Secretion of soluble ST2 - possible explanation for systemic immunosuppression after heart surgery.Thorac. Cardiovasc. Surg.57, 25–29 (2009).
  • Porcel JM , Martinez-AlonsoM, CaoG, BielsaS, SopenaA, EsquerdaA: Biomarkers of heart failure in pleural fluid.Chest136(3), 671–677 (2009).
  • Brunner M , KrennC, RothGet al. : Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma.Intensive Care Med.30, 1468–1473 (2004).
  • Sweet MJ , LeungBP, KangDet al. : A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of toll-like receptor 4 expression.J. Immunol.166, 6633–6639 (2001).
  • Kanda M , Ohto-OzakiH, KuroiwaK, TominagaS, WatanabeE, IwahanaH: Elevation of ST2 protein levels in cerebrospinal fluid following subarachnoid hemorrhage.Acta Neurol. Scand.113, 327–333 (2006).
  • Becerra A , WarkeRV, de Bosch N, Rothman AL, Bosch I: Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine41, 114–120 (2008).
  • Wagenaar JF , GasemMH, GorisMGet al. : Soluble ST2 levels are associated with bleeding in patients with severe leptospirosis.PLoS Negl. Trop. Dis.3, E453 (2009).
  • Bruneau S , Le Berre L, Herve C et al.: Potential role of soluble ST2 protein in idiopathic nephrotic syndrome recurrence following kidney transplantation. Am. J. Kidney Dis.54(3), 522–532 (2009).
  • Mollica L , De Marchis F, Spitaleri A et al.: Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem. Biol.14, 431–441 (2007).
  • Girard JP : A direct inhibitor of HMGB1 cytokine.Chem. Biol.14, 345–347 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.